Claudin-20 promotes an aggressive phenotype in human breast cancer cells

References

• Terry S, Nie M, Matter K, Balda MS. Rho signaling and tight junction functions. Physiology (Bethesda) 2010; 25:16 - 26; http://dx.doi.org/10.1152/physiol.00034.2009; PMID: 20134025
   PubMed Web of Science ®Google Scholar
• Balda MS, Matter K. Tight junctions at a glance. J Cell Sci 2008; 121:3677 - 82; http://dx.doi.org/10.1242/jcs.023887; PMID: 18987354
   PubMed Web of Science ®Google Scholar
• Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009; 1788:872 - 91; http://dx.doi.org/10.1016/j.bbamem.2008.11.005; PMID: 19059202
   PubMed Web of Science ®Google Scholar
• Lapointe TK, O’Connor PM, Jones NL, Menard D, Buret AG. Interleukin-1 receptor phosphorylation activates Rho kinase to disrupt human gastric tight junctional claudin-4 during Helicobacter pylori infection. Cell Microbiol 2010; 12:692 - 703; http://dx.doi.org/10.1111/j.1462-5822.2010.01429.x; PMID: 20070312
   PubMed Web of Science ®Google Scholar
• Martin TA, Das T, Mansel RE, Jiang WG. Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid. J Cell Biochem 2007; 101:155 - 66; http://dx.doi.org/10.1002/jcb.21162; PMID: 17243118
   PubMed Web of Science ®Google Scholar
• Paschoud S, Bongiovanni M, Pache JC, Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol 2007; 20:947 - 54; http://dx.doi.org/10.1038/modpathol.3800835; PMID: 17585317
   PubMed Web of Science ®Google Scholar
• Turunen M, Talvensaari-Mattila A, Soini Y, Santala MZ. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res 2009; 29:5185 - 9; PMID: 20044634
   PubMed Web of Science ®Google Scholar
• Arshad F, Wang L, Sy C, Avraham S, Avraham HK. Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog Res Int 2010; 2011:920509; PMID: 21253507
   PubMedGoogle Scholar
• Martin TA, Mason MD, Jiang WG. Tight junctions in cancer metastasis. Front Biosci (Landmark Ed) 2011; 16:898 - 936; http://dx.doi.org/10.2741/3726; PMID: 21196209
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Ozawa M. J The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. Cell Sci 2002; 117:1675 - 85; http://dx.doi.org/10.1242/jcs.01004
   Web of Science ®Google Scholar
• Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008; 1778:631 - 45; http://dx.doi.org/10.1016/j.bbamem.2007.10.018; PMID: 18036336
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68:403 - 29; http://dx.doi.org/10.1146/annurev.physiol.68.040104.131404; PMID: 16460278
   PubMed Web of Science ®Google Scholar
• Martin TA, Jiang WG. Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells. Methods Mol Biol 2011; 762:383 - 407; http://dx.doi.org/10.1007/978-1-61779-185-7_28; PMID: 21717372
   PubMedGoogle Scholar
• Escudero-Esparza A, Jiang WG, Martin TA. Claudin-5 participates in the regulation of endothelial cell motility. Mol Cell Biochem 2012; 362:71 - 85; http://dx.doi.org/10.1007/s11010-011-1129-2; PMID: 22038628
   PubMed Web of Science ®Google Scholar
• Arabzadeh A, Troy TC, Turksen K. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis. BMC Cancer 2007; 7:196 - 201; http://dx.doi.org/10.1186/1471-2407-7-196; PMID: 17945025
   PubMed Web of Science ®Google Scholar
• Satake S, Semba S, Matsuda Y, Usami Y, Chiba H, Sawada N, Kasuga M, Yokozaki H. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol Int 2008; 58:156 - 63; http://dx.doi.org/10.1111/j.1440-1827.2007.02204.x; PMID: 18251778
   PubMed Web of Science ®Google Scholar
• Song X, Li X, Tang Y, Chen H, Wong B, Wang J, Chen M. Expression of claudin-2 in the multistage process of gastric carcinogenesis. Histol Histopathol 2008; 23:673 - 82; PMID: 18366005
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Kusumi T, Sato F, Kawasaki H, Shibata S, Ohashi M, Hakamada K, Sasaki M, Kijima H. Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma. Biomed Res 2008; 29:71 - 6; http://dx.doi.org/10.2220/biomedres.29.71; PMID: 18480547
   PubMed Web of Science ®Google Scholar
• Tsunoda S, Smith E, De Young NJ, Wang X, Tian ZQ, Liu JF, Jamieson GG, Drew PA. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. Oncol Rep 2009; 21:1067 - 73; http://dx.doi.org/10.3892/or_00000325; PMID: 19288010
   PubMed Web of Science ®Google Scholar
• Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, Smalley KS. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007; 170:709 - 21; http://dx.doi.org/10.2353/ajpath.2007.060343; PMID: 17255337
   PubMed Web of Science ®Google Scholar
• Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, et al. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 2007; 27:6A 3729 - 34; PMID: 17970035
   PubMed Web of Science ®Google Scholar
• Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K, et al. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 2009; 29:851 - 7; PMID: 19414319
   PubMed Web of Science ®Google Scholar
• Gröne J, Weber B, Staub E, Heinze M, Klaman I, Pilarsky C, Hermann K, Castanos-Velez E, Röpcke S, Mann B, et al. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. Int J Colorectal Dis 2007; 22:651 - 9; http://dx.doi.org/10.1007/s00384-006-0197-3; PMID: 17047970
   PubMed Web of Science ®Google Scholar
• Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 2008; 75:177 - 85; http://dx.doi.org/10.1159/000124978; PMID: 18550915
   PubMed Web of Science ®Google Scholar
• Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, et al. Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep 2008; 19:953 - 9; PMID: 18357381
   PubMed Web of Science ®Google Scholar
• Blanchard AA, Skliris GP, Watson PH, Murphy LC, Penner C, Tomes L, Young TL, Leygue E, Myal Y. Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 2009; 454:647 - 56; http://dx.doi.org/10.1007/s00428-009-0770-6; PMID: 19387682
   PubMed Web of Science ®Google Scholar
• Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, Jirstrom K, Landberg G, Martin F, Duffy MJ, et al. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 2009; 124:2088 - 97; http://dx.doi.org/10.1002/ijc.24159; PMID: 19142967
   PubMed Web of Science ®Google Scholar
• Chen Y, Medvedev A, Ruzanov P, Marvin KW, Jetten AM. cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 1997; 41:40 - 8; http://dx.doi.org/10.1006/geno.1997.4524; PMID: 9126480
   PubMed Web of Science ®Google Scholar
• Rizzolo LJ, Chen X, Weitzman M, Sun R, Zhang H. Analysis of the RPE transcriptome reveals dynamic changes during the development of the outer blood-retinal barrier. Mol Vis 2007; 13:1259 - 73; PMID: 17679949
   PubMed Web of Science ®Google Scholar
• Price MG, Davis CF, Deng F, Burgess DL. The α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor trafficking regulator “stargazin” is related to the claudin family of proteins by Its ability to mediate cell-cell adhesion. J Biol Chem 2005; 280:19711 - 20; http://dx.doi.org/10.1074/jbc.M500623200; PMID: 15760900
   PubMed Web of Science ®Google Scholar
• Jain A, Tindell CA, Laux I, Hunter JB, Curran J, Galkin A, Afar DE, Aronson N, Shak S, Natale RB, et al. Epithelial membrane protein-1 is a biomarker of gefitinib resistance. Proc Natl Acad Sci U S A 2005; 102:11858 - 63; http://dx.doi.org/10.1073/pnas.0502113102; PMID: 16087880
   PubMed Web of Science ®Google Scholar
• Piechocki MP, Yoo GH, Dibbley SK, Lonardo F. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu. Cancer Res 2007; 67:6825 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-07-0765; PMID: 17638894
   PubMed Web of Science ®Google Scholar
• Wen H, Watry DD, Marcondes MC, Fox HS, Fox S. Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol 2004; 24:8408 - 17; http://dx.doi.org/10.1128/MCB.24.19.8408-8417.2004; PMID: 15367662
   PubMed Web of Science ®Google Scholar
• Charoenphandhu N, Wongdee K, Tudpor K, Pandaranandaka J, Krishnamra N. Chronic metabolic acidosis upregulated claudin mRNA expression in the duodenal enterocytes of female rats. Life Sci 2007; 80:1729 - 37; http://dx.doi.org/10.1016/j.lfs.2007.01.063; PMID: 17383680
   PubMed Web of Science ®Google Scholar
• Webb PG, Spillman MA, Baumgartner HK. Claudins play a role in normal and tumor cell motility. BMC Cell Biol 2013; 14:19; http://dx.doi.org/10.1186/1471-2121-14-19; PMID: 23521713
   PubMed Web of Science ®Google Scholar
• Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004; 164:1627 - 33; http://dx.doi.org/10.1016/S0002-9440(10)63721-2; PMID: 15111309
   PubMed Web of Science ®Google Scholar
• Soini Y. Claudins 2, 3, 4, and 5 in Paget’s disease and breast carcinoma. Hum Pathol 2004; 35:1531 - 6; http://dx.doi.org/10.1016/j.humpath.2004.09.015; PMID: 15619213
   PubMed Web of Science ®Google Scholar
• Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, Jirstrom K, Landberg G, Martin F, Duffy MJ, et al. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 2009; 124:2088 - 97; http://dx.doi.org/10.1002/ijc.24159; PMID: 19142967
   PubMed Web of Science ®Google Scholar
• Pfaffl MW, Hagelei M. Validities of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR. Biotechnol Lett 2001; 23:275 - 82; http://dx.doi.org/10.1023/A:1005658330108
   Web of Science ®Google Scholar